Literature DB >> 3921300

Differences in modifications of cytoplasmic free Ca2+ concentration and 86Rb+ influx in human neoplastic B cells by antibodies to mu- relative to delta-Ig heavy chains.

R Heikkilä, E Ruud, S Funderud, T Godal.   

Abstract

Cytoplasmic free Ca2+ concentration and influx of 86Rb+ (K+ analogue) were determined during the first minutes after stimulation of neoplastic human B cells and B cell lines by antibodies to surface Ig. The Ca2+ concentration increased in the great majority of samples (41 of 48). All of four B cell lines also responded, providing formal evidence that accessory cells are not required for this early, surface Ig-mediated event. Antibodies to delta as well as mu, heavy chains (anti-delta and anti-mu) could induce both Ca2+ and 86Rb+ responses. 86Rb+ responders were found within the group of Ca2+ responders, but no quantitative relation was observed between the two responses. In cells expressing both sIgM and sIgD, antibodies to delta heavy chains were more potent than those to mu heavy chains in inducing Ca2+ responses, whereas the opposite pattern was seen with regard to 86Rb+ responses. These results demonstrate that sIgM and sIgD can deliver different biochemical signals to the cell.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921300      PMCID: PMC1576936     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Immunoglobulin-receptors revisited.

Authors:  E S Vitetta; J W Uhr
Journal:  Science       Date:  1975-09-19       Impact factor: 47.728

2.  Regulation of sodium and potassium transport in phytohemagglutinin-stimulated human blood lymphocytes.

Authors:  G B Segel; W Simon; M A Lichtman
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

Review 3.  Inositol phospholipids and cell surface receptor function.

Authors:  R H Michell
Journal:  Biochim Biophys Acta       Date:  1975-03-25

4.  Three new fragments, F(ab) 2 , F(c) 2 , and Fab-c, obtained by papain proteolysis of normal human IgG.

Authors:  T E Michaelsen; J B Natvig
Journal:  Scand J Immunol       Date:  1972       Impact factor: 3.487

5.  Pepsin digestion of human G-myeloma proteins of different subclasses. I. The characteristic features of pepsin cleavage as a function of time.

Authors:  M W Turner; H H Bennich; J B Natvig
Journal:  Clin Exp Immunol       Date:  1970-11       Impact factor: 4.330

6.  T-cell mitogens cause early changes in cytoplasmic free Ca2+ and membrane potential in lymphocytes.

Authors:  R Y Tsien; T Pozzan; T J Rink
Journal:  Nature       Date:  1982-01-07       Impact factor: 49.962

7.  Anti-immunoglobulin-induced potassium flux in relation to capping and DNA synthesis. An analysis in monoclonal human B lymphoma cell populations.

Authors:  R Heikkilä; T Godal; A Henriksen; J G Iversen
Journal:  Exp Cell Res       Date:  1981-12       Impact factor: 3.905

8.  Mouse immunoglobulin receptors on lymphocytes: identification of IgM and IgD molecules by tryptic cleavage and a postulated role for cell surface IgD.

Authors:  A Bourgois; E R Abney; R M Parkhouse
Journal:  Eur J Immunol       Date:  1977-04       Impact factor: 5.532

9.  Circulating immune complexes and prognosis in human malignant lymphoma, a prospective study.

Authors:  H E Heier; T O Landaas; P F Marton
Journal:  Int J Cancer       Date:  1979-03-15       Impact factor: 7.396

10.  Memory B cells at successive stages of differentiation. Affinity maturation and the role of IgD receptors.

Authors:  L A Herzenberg; S J Black; T Tokuhisa; L A Herzenberg
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

View more
  1 in total

1.  The specific induction of myc protooncogene expression in normal human B cells is not a sufficient event for acquisition of competence to proliferate.

Authors:  E Smeland; T Godal; E Ruud; K Beiske; S Funderud; E A Clark; S Pfeifer-Ohlsson; R Ohlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.